Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	beta-adrenergic receptor kinase activity	GRK5 GRK2 GRK3	3.06e-06	4	184	3	GO:0047696
GeneOntologyMolecularFunction	protein kinase activity	DDR1 ATR GRK5 OBSCN BAZ1B YES1 MKNK1 PIKFYVE CCNH TGFBR3 LIMK1 GRK2 GRK3 BTK MAPK9 MAPK10 EPHA7 EPHA8	1.17e-05	600	184	18	GO:0004672
GeneOntologyMolecularFunction	G protein-coupled receptor kinase activity	GRK5 GRK2 GRK3	2.62e-05	7	184	3	GO:0004703
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	DDR1 ATR GRK5 OBSCN BAZ1B YES1 MKNK1 PIKFYVE CCNH TGFBR3 LIMK1 PANK2 GRK2 GRK3 BTK MAPK9 MAPK10 EPHA7 EPHA8	3.16e-05	709	184	19	GO:0016773
GeneOntologyMolecularFunction	kinase activity	DDR1 ATR GRK5 OBSCN BAZ1B YES1 MKNK1 PIKFYVE CCNH TGFBR3 LIMK1 PANK2 GRK2 GRK3 BTK MAPK9 MAPK10 EPHA7 EPHA8	8.56e-05	764	184	19	GO:0016301
GeneOntologyMolecularFunction	JUN kinase activity	MAPK9 MAPK10	2.52e-04	3	184	2	GO:0004705
Domain	GPCR_kinase	GRK5 GRK2 GRK3	3.25e-05	7	185	3	IPR000239
Domain	DAD_dom	FHOD3 FMNL2 DIAPH3	5.16e-05	8	185	3	IPR014767
Domain	DAD	FHOD3 FMNL2 DIAPH3	5.16e-05	8	185	3	PS51231
Domain	WAC_Acf1_DNA_bd	BAZ1B BAZ1A	9.76e-05	2	185	2	PF10537
Domain	WAC	BAZ1B BAZ1A	9.76e-05	2	185	2	PS51136
Domain	WSTF_Acf1_Cbp146	BAZ1B BAZ1A	9.76e-05	2	185	2	IPR013136
Domain	GBD/FH3_dom	FHOD3 FMNL2 DIAPH3	1.49e-04	11	185	3	IPR014768
Domain	GBD_FH3	FHOD3 FMNL2 DIAPH3	1.49e-04	11	185	3	PS51232
Domain	Kinase-like_dom	DDR1 ATR GRK5 OBSCN YES1 MKNK1 LIMK1 DST GRK2 GRK3 BTK MAPK9 MAPK10 EPHA7 EPHA8	3.37e-04	542	185	15	IPR011009
Domain	FH2	FHOD3 FMNL2 DIAPH3	3.99e-04	15	185	3	PS51444
Domain	FH2_Formin	FHOD3 FMNL2 DIAPH3	3.99e-04	15	185	3	IPR015425
Domain	FH2	FHOD3 FMNL2 DIAPH3	3.99e-04	15	185	3	PF02181
Domain	FH2	FHOD3 FMNL2 DIAPH3	3.99e-04	15	185	3	SM00498
Domain	PROTEIN_KINASE_TYR	DDR1 OBSCN YES1 BTK EPHA7 EPHA8	4.08e-04	97	185	6	PS00109
Domain	Tyr_kinase_AS	DDR1 OBSCN YES1 BTK EPHA7 EPHA8	4.08e-04	97	185	6	IPR008266
Domain	G8_domain	PKHD1L1 CEMIP	5.78e-04	4	185	2	IPR019316
Domain	G8	PKHD1L1 CEMIP	5.78e-04	4	185	2	PS51484
Domain	G8	PKHD1L1 CEMIP	5.78e-04	4	185	2	SM01225
Domain	G8	PKHD1L1 CEMIP	5.78e-04	4	185	2	PF10162
Domain	PROTEIN_KINASE_ATP	DDR1 GRK5 OBSCN YES1 MKNK1 LIMK1 GRK2 GRK3 BTK MAPK9 MAPK10 EPHA7 EPHA8	6.79e-04	459	185	13	PS00107
Domain	aa-tRNA-synth_I_CS	WARS1 IARS1 LARS1	6.99e-04	18	185	3	IPR001412
Domain	AA_TRNA_LIGASE_I	WARS1 IARS1 LARS1	8.24e-04	19	185	3	PS00178
Domain	DDT	BAZ1B BAZ1A	9.57e-04	5	185	2	SM00571
Domain	DDT_dom	BAZ1B BAZ1A	9.57e-04	5	185	2	IPR018501
Domain	WHIM1_dom	BAZ1B BAZ1A	9.57e-04	5	185	2	IPR028942
Domain	WHIM2_dom	BAZ1B BAZ1A	9.57e-04	5	185	2	IPR028941
Domain	WSD	BAZ1B BAZ1A	9.57e-04	5	185	2	PF15613
Domain	WHIM1	BAZ1B BAZ1A	9.57e-04	5	185	2	PF15612
Domain	MAPK_JNK	MAPK9 MAPK10	9.57e-04	5	185	2	IPR008351
Domain	Prot_kinase_dom	DDR1 GRK5 OBSCN YES1 MKNK1 LIMK1 GRK2 GRK3 BTK MAPK9 MAPK10 EPHA7 EPHA8	1.21e-03	489	185	13	IPR000719
Domain	SH3_1	ARHGAP42 NPHP1 YES1 DST BTK ARHGEF6 TP53BP2	1.26e-03	164	185	7	PF00018
Domain	PROTEIN_KINASE_DOM	DDR1 GRK5 OBSCN YES1 MKNK1 LIMK1 GRK2 GRK3 BTK MAPK9 MAPK10 EPHA7 EPHA8	1.30e-03	493	185	13	PS50011
Domain	VWFA	VWA3A ITGAL ITGB3 MDN1 CLCA2	1.33e-03	82	185	5	PS50234
Domain	DDT	BAZ1B BAZ1A	1.43e-03	6	185	2	PS50827
Domain	Val/Leu/Ile-tRNA-synth_edit	IARS1 LARS1	1.43e-03	6	185	2	IPR009008
Domain	Anticodon_1	IARS1 LARS1	1.43e-03	6	185	2	PF08264
Domain	M/V/L/I-tRNA-synth_anticd-bd	IARS1 LARS1	1.43e-03	6	185	2	IPR013155
Domain	-	IARS1 LARS1	1.43e-03	6	185	2	3.90.740.10
Domain	SH3	ARHGAP42 NPHP1 OBSCN YES1 DST BTK ARHGEF6 TP53BP2	1.43e-03	216	185	8	PS50002
Domain	ACTININ_2	FLNB SYNE1 DST	1.46e-03	23	185	3	PS00020
Domain	ACTININ_1	FLNB SYNE1 DST	1.46e-03	23	185	3	PS00019
Domain	Actinin_actin-bd_CS	FLNB SYNE1 DST	1.46e-03	23	185	3	IPR001589
Domain	VWA	VWA3A ITGAL ITGB3 MDN1 CLCA2	1.48e-03	84	185	5	SM00327
Domain	SH3_domain	ARHGAP42 NPHP1 OBSCN YES1 DST BTK ARHGEF6 TP53BP2	1.61e-03	220	185	8	IPR001452
Domain	Pkinase_Tyr	DDR1 YES1 LIMK1 BTK EPHA7 EPHA8	1.81e-03	129	185	6	PF07714
Domain	Tyr_kinase_cat_dom	DDR1 YES1 BTK EPHA7 EPHA8	1.82e-03	88	185	5	IPR020635
Domain	TyrKc	DDR1 YES1 BTK EPHA7 EPHA8	1.82e-03	88	185	5	SM00219
Domain	PH	ARHGAP42 RASGRF2 DOCK9 OBSCN PLEKHM1 GRK2 GRK3 BTK ARHGEF6	1.86e-03	278	185	9	SM00233
Domain	PH_DOMAIN	ARHGAP42 RASGRF2 DOCK9 OBSCN PLEKHM1 GRK2 GRK3 BTK ARHGEF6	1.90e-03	279	185	9	PS50003
Domain	PH_domain	ARHGAP42 RASGRF2 DOCK9 OBSCN PLEKHM1 GRK2 GRK3 BTK ARHGEF6	1.95e-03	280	185	9	IPR001849
Domain	aa-tRNA-synth_Ia	IARS1 LARS1	1.98e-03	7	185	2	IPR002300
Domain	tRNA-synt_1	IARS1 LARS1	1.98e-03	7	185	2	PF00133
Domain	AP_complex_ssu	AP1S3 AP1S1	1.98e-03	7	185	2	IPR016635
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_TNF_JNK_SIGNALING_PATHWAY	JUN MAPK9 MAPK10	1.07e-05	5	146	3	M49005
Pathway	KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY	JUN MAPK9 MAPK10	1.07e-05	5	146	3	M47570
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY	MAPK9 MAPK10 HTT	2.13e-05	6	146	3	M47680
Pathway	KEGG_MEDICUS_REFERENCE_IL1_IL1R_JNK_SIGNALING_PATHWAY	JUN MAPK9 MAPK10 IL1RAP	3.79e-05	19	146	4	M47471
Pathway	KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY	JUN MAPK9 MAPK10	5.87e-05	8	146	3	M47814
Pathway	PID_CDC42_PATHWAY	YES1 JUN LIMK1 DIAPH3 MAPK9 ARHGEF6	8.46e-05	70	146	6	M81
Pathway	REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS	JUN MAPK9 MAPK10	1.24e-04	10	146	3	MM15135
Pathway	REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS	JUN MAPK9 MAPK10	1.24e-04	10	146	3	M13962
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	FLNB WARS1 CASP14 TBPL1 IARS1 DHX40 BAG2 LARS1 BAZ1B RBM28 PGD GRSF1 PAICS HNRNPH1 HNRNPH3 RHOG DST MDN1 BAZ1A SERPINB12 A2ML1 PYGB EBNA1BP2 TOP2B TP53BP2	1.11e-07	1353	190	25	29467282
Pubmed	MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates.	MKNK1 JUN MAPK9 TOP2B	5.94e-07	13	190	4	9155018
Pubmed	A selective small-molecule inhibitor of c-Jun N-terminal kinase 1.	JUN MAPK9 MAPK10	6.39e-07	4	190	3	19527717
Pubmed	DLK-dependent signaling is important for somal but not axonal degeneration of retinal ganglion cells following axonal injury.	JUN MAPK9 MAPK10	6.39e-07	4	190	3	24878510
Pubmed	JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death.	JUN MAPK9 MAPK10	6.39e-07	4	190	3	22353563
Pubmed	c-Jun N-terminal kinase 3 deficiency protects neurons from axotomy-induced death in vivo through mechanisms independent of c-Jun phosphorylation.	JUN MAPK9 MAPK10	6.39e-07	4	190	3	15528206
Pubmed	Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function.	GRK5 GRK2 GRK3	6.39e-07	4	190	3	8917529
Pubmed	c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis.	JUN MAPK9 MAPK10	6.39e-07	4	190	3	16824735
Pubmed	Neuronal c-Jun is required for successful axonal regeneration, but the effects of phosphorylation of its N-terminus are moderate.	JUN MAPK9 MAPK10	6.39e-07	4	190	3	22372722
Pubmed	Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder.	GRK5 GRK2 GRK3	6.39e-07	4	190	3	21784156
Pubmed	Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C.	GRK5 GRK2 GRK3	6.39e-07	4	190	3	8662816
Pubmed	Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice.	PPARG APOE GRK2	1.59e-06	5	190	3	26670611
Pubmed	The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development.	JUN MAPK9 MAPK10	1.59e-06	5	190	3	10230788
Pubmed	Enhanced contractility and decreased beta-adrenergic receptor kinase-1 in mice lacking endogenous norepinephrine and epinephrine.	GRK5 GRK2 GRK3	1.59e-06	5	190	3	10338466
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	WWC3 SYNE1 RALGAPA2 CEMIP RIMKLB MTUS1 TLE4	1.65e-06	103	190	7	10574462
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	GPD2 FLNB WARS1 IARS1 SYNE1 LARS1 TMED7 OGDH PGD PAICS HNRNPH1 DST MDN1 PACS2 PYGB HYDIN MYO16	2.44e-06	807	190	17	30575818
Pubmed	Neuroprotection by histone deacetylase-related protein.	JUN MAPK9 MAPK10	3.17e-06	6	190	3	16611996
Pubmed	Combinatorial depletions of G-protein coupled receptor kinases in immune cells identify pleiotropic and cell type-specific functions.	GRK5 GRK2 GRK3	3.17e-06	6	190	3	36451830
Pubmed	beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein.	GRK5 GRK2 GRK3	3.17e-06	6	190	3	9826657
Pubmed	A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria.	JUN MAPK9 MAPK10	3.17e-06	6	190	3	12167088
Pubmed	Determination of bradykinin B2 receptor in vivo phosphorylation sites and their role in receptor function.	GRK5 GRK2 GRK3	5.53e-06	7	190	3	11517230
Pubmed	Members of the G protein-coupled receptor kinase family that phosphorylate the beta2-adrenergic receptor facilitate sequestration.	GRK5 GRK2 GRK3	5.53e-06	7	190	3	8672451
Pubmed	Selective interaction of JNK protein kinase isoforms with transcription factors.	JUN MAPK9 MAPK10	8.81e-06	8	190	3	8654373
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	GPD2 FLNB WARS1 ATR IARS1 SYNE1 SPTLC1 LARS1 BAZ1B OGDH PGD GRSF1 PAICS HNRNPH1 HNRNPH3 MDN1 CLCA2 BAZ1A SERPINB12 SGO2 EBNA1BP2 TOP2B	1.21e-05	1425	190	22	30948266
Pubmed	Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase.	JUN MAPK9 MAPK10	1.32e-05	9	190	3	9596579
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	GPD2 FLNB CASP14 IARS1 SYNE1 BAG2 LARS1 BAZ1B RBM28 YES1 HNRNPH1 HNRNPH3 DST MDN1 BAZ1A SERPINB12 EBNA1BP2 TOP2B	1.46e-05	1024	190	18	24711643
Pubmed	JNK initiates a cytokine cascade that causes Pax2 expression and closure of the optic fissure.	JUN MAPK9 MAPK10	1.87e-05	10	190	3	12756228
Pubmed	Required roles of Bax and JNKs in central and peripheral nervous system death of retinoblastoma-deficient mice.	JUN MAPK9 MAPK10	1.87e-05	10	190	3	17984095
Pubmed	A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates.	JUN MAPK9 MAPK10	1.87e-05	10	190	3	12788955
Pubmed	The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis.	JUN MAPK9 MAPK10	1.87e-05	10	190	3	15375216
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	PNMA1 LARS1 BAZ1B RBM28 OGDH GRSF1 HNRNPH1 HNRNPH3 MDN1 BAZ1A SGO2 EBNA1BP2 HSPA14 TOP2B HERC5	2.05e-05	759	190	15	35915203
Pubmed	Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.	FLNB WARS1 OGDH PGD IFIT3 NFIX HERC5	2.16e-05	152	190	7	16009940
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	FLNB IARS1 OGDH ITGB3 HNRNPH1 JUN MDN1 GRK2 BTK HTT	2.17e-05	344	190	10	30333137
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	FLNB PDE2A WARS1 SYNE1 SIPA1L3 LARS1 DDIT4L APOE FMNL2 PAICS ME3 RHOG LIMK1 FRY NPRL2 DST COMMD1 ASB3 PNMA2 AFF4	2.75e-05	1285	190	20	35914814
Pubmed	Irbesartan increased PPARγ activity in vivo in white adipose tissue of atherosclerotic mice and improved adipose tissue dysfunction.	PPARG APOE	2.97e-05	2	190	2	21296052
Pubmed	A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.	GRK5 GRK2	2.97e-05	2	190	2	18425130
Pubmed	Regulation of the platelet-derived growth factor receptor-beta by G protein-coupled receptor kinase-5 in vascular smooth muscle cells involves the phosphatase Shp2.	GRK5 APOE	2.97e-05	2	190	2	17018529
Pubmed	Dysfunction of G protein-coupled receptor kinases in Alzheimer's disease.	GRK5 GRK2	2.97e-05	2	190	2	20730384
Pubmed	Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice.	MAPK9 MAPK10	2.97e-05	2	190	2	29899326
Pubmed	Gene- Gene Interaction between PPARG and APOE Gene on Late-Onset Alzheimer's Disease: A Case- Control Study in Chinese Han Population.	PPARG APOE	2.97e-05	2	190	2	28346566
Pubmed	Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.	GRK5 GRK2	2.97e-05	2	190	2	21127457
Pubmed	Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation.	APOE IL1RAP	2.97e-05	2	190	2	38563353
Pubmed	CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways.	ITGAL CD40LG	2.97e-05	2	190	2	12391193
Pubmed	Autophosphorylation properties of inactive and active JNK2.	JUN MAPK9	2.97e-05	2	190	2	17637567
Pubmed	KLF9 and JNK3 Interact to Suppress Axon Regeneration in the Adult CNS.	MAPK9 MAPK10	2.97e-05	2	190	2	28871032
Pubmed	Antiatherogenic effect of pioglitazone on uremic apolipoprotein E knockout mice by modulation of the balance of regulatory and effector T cells.	PPARG APOE	2.97e-05	2	190	2	21868013
Pubmed	Cloning of GRK2 cDNA from S49 murine lymphoma cells.	GRK2 GRK3	2.97e-05	2	190	2	8638670
Pubmed	Genetic variation and cognitive dysfunction one year after cardiac surgery.	APOE ITGB3	2.97e-05	2	190	2	23384292
Pubmed	Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.	PPARG APOE	2.97e-05	2	190	2	22539598
Pubmed	Dissecting the roles of GRK2 and GRK3 in μ-opioid receptor internalization and β-arrestin2 recruitment using CRISPR/Cas9-edited HEK293 cells.	GRK2 GRK3	2.97e-05	2	190	2	33060647
Pubmed	Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease.	PPARG HTT	2.97e-05	2	190	2	18640979
Pubmed	Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus.	APOE PANK2	2.97e-05	2	190	2	26547561
Pubmed	Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropism.	JUN NFIX	2.97e-05	2	190	2	16928756
Pubmed	Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.	PPARG APOE	2.97e-05	2	190	2	26890773
Pubmed	Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity.	JUN BTK	2.97e-05	2	190	2	9108083
Pubmed	Pro12Ala sequence variant of the PPARG gene is associated with postprandial hypertriglyceridemia in non-E3/E3 patients with the metabolic syndrome.	PPARG APOE	2.97e-05	2	190	2	16916989
Pubmed	Identification of four splice variants of the mouse stress-activated protein kinase JNK/SAPK alpha-isoform.	MAPK9 MAPK10	2.97e-05	2	190	2	8817558
Pubmed	alpha Pix enhances mutant huntingtin aggregation.	ARHGEF6 HTT	2.97e-05	2	190	2	19969308
Pubmed	Serine palmitoyltransferase (SPT) deficient mice absorb less cholesterol.	SPTLC1 APOE	2.97e-05	2	190	2	19416652
Pubmed	G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans.	GRK5 GRK2	2.97e-05	2	190	2	19487588
Pubmed	X Chromosome-wide Association Study Identifies a Susceptibility Locus for Inflammatory Bowel Disease in Koreans.	CD40LG ARHGEF6	2.97e-05	2	190	2	28333213
Pubmed	Requirement for CD154 in the progression of atherosclerosis.	APOE CD40LG	2.97e-05	2	190	2	10546000
Pubmed	JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration.	MAPK9 MAPK10	2.97e-05	2	190	2	19014392
Pubmed	PPARγ Pro12Ala and His447His polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis.	PPARG APOE	2.97e-05	2	190	2	26125935
Pubmed	Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice.	APOE CD40LG	2.97e-05	2	190	2	18778362
Pubmed	Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3.	GRK2 GRK3	2.97e-05	2	190	2	10198406
Pubmed	G-protein coupled receptor kinase 2 and 3 expression in human detrusor cultured smooth muscle cells.	GRK2 GRK3	2.97e-05	2	190	2	11762794
Pubmed	Myocardial G protein receptor-coupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure.	GRK5 GRK2	2.97e-05	2	190	2	22196842
Pubmed	Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation.	GRK5 GRK2	2.97e-05	2	190	2	16849637
Pubmed	Lipocalin prostaglandin D synthase and PPARγ2 coordinate to regulate carbohydrate and lipid metabolism in vivo.	PPARG PTGDS	2.97e-05	2	190	2	22792179
Pubmed	Knockout of the l-pgds gene aggravates obesity and atherosclerosis in mice.	APOE PTGDS	2.97e-05	2	190	2	19070593
Pubmed	CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.	APOE CD40LG	2.97e-05	2	190	2	18349125
Pubmed	Constitutive activity of JNK2 alpha2 is dependent on a unique mechanism of MAPK activation.	JUN MAPK9	2.97e-05	2	190	2	18940813
Pubmed	G protein--coupled receptor kinases.	GRK2 GRK3	2.97e-05	2	190	2	8035170
Pubmed	Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders.	PNMA1 PNMA2	2.97e-05	2	190	2	10050892
Pubmed	Gene-gene interaction of PPARgamma and ApoE affects coronary heart disease risk.	PPARG APOE	2.97e-05	2	190	2	14659862
Pubmed	Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.	PPARG APOE	2.97e-05	2	190	2	20508203
Pubmed	Identification of a specific domain responsible for JNK2alpha2 autophosphorylation.	JUN MAPK9	2.97e-05	2	190	2	15637069
Pubmed	Digenic inheritance of severe insulin resistance in a human pedigree.	PPARG PPP1R3A	2.97e-05	2	190	2	12118251
Pubmed	The E3 ligase HERC5 promotes antimycobacterial responses in macrophages by ISGylating the phosphatase PTEN.	HERC6 HERC5	2.97e-05	2	190	2	37279284
Pubmed	G protein-coupled receptor kinase-5 attenuates atherosclerosis by regulating receptor tyrosine kinases and 7-transmembrane receptors.	GRK5 APOE	2.97e-05	2	190	2	22095977
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	FLNB WARS1 IARS1 SPTLC1 LARS1 TMED7 YES1 PGD GRSF1 PAICS HNRNPH3 RHOG MTMR4 DST TMTC3 BAZ1A RAD1 DIAPH3 EBNA1BP2 PLOD2	3.14e-05	1297	190	20	33545068
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	WARS1 TBPL1 IARS1 BAG2 SPTLC1 LARS1 BAZ1B RBM28 GRSF1 PAICS HNRNPH1 HNRNPH3 RHOG AP1S1 MDN1 BTK SAP30BP BRD9 EBNA1BP2 TOP2B	3.93e-05	1318	190	20	30463901
Pubmed	The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer.	IARS1 LARS1 RBM28 JUN PANK2	4.49e-05	71	190	5	29346117
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	FLNB DHX40 SYNE1 OGDH DST MDN1 UTY TOP2B	4.73e-05	234	190	8	36243803
Pubmed	p38 is essential for the assembly and stability of macromolecular tRNA synthetase complex: implications for its physiological significance.	WARS1 IARS1 LARS1	5.59e-05	14	190	3	12060739
Pubmed	Expression of multiple formins in adult tissues and during developmental stages of mouse brain.	FHOD3 FMNL2 DIAPH3	5.59e-05	14	190	3	26272686
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	CASP14 IARS1 LARS1 BAZ1B SRP19 RBM28 PGD PAICS HNRNPH1 HNRNPH3 SERPINB12 EBNA1BP2 TOP2B	5.69e-05	641	190	13	36057605
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	WARS1 CASP14 DHX40 PGD HNRNPH1 HNRNPH3 JUN DST BAZ1A SERPINB12 TP53BP2	6.32e-05	472	190	11	38943005
Pubmed	Vti1b promotes TRPV1 sensitization during inflammatory pain.	FLNB IARS1 DOCK9 OGDH HNRNPH1 DST	7.34e-05	127	190	6	30335684
Pubmed	Association of a polymorphism of the apolipoprotein E gene with chronic kidney disease in Japanese individuals with metabolic syndrome.	PPARG APOE PPP1R3A LIMK1 CD40LG	7.50e-05	79	190	5	19056482
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	MTERF1 IARS1 LARS1 PPARG JUN MDN1 BAZ1A NFIX TLE4 A2ML1 MAPK9 PLOD2 HSPA14 TOP2B HERC5	8.09e-05	857	190	15	25609649
Pubmed	JNK Isoforms Are Involved in the Control of Adult Hippocampal Neurogenesis in Mice, Both in Physiological Conditions and in an Experimental Model of Temporal Lobe Epilepsy.	MAPK9 MAPK10	8.87e-05	3	190	2	30685843
Pubmed	Phosphorylation of c-jun mediated by MAP kinases.	JUN MAPK10	8.87e-05	3	190	2	1922387
Pubmed	Genes, fat intake, and cardiovascular disease risk factors in the Quebec Family Study.	PPARG APOE	8.87e-05	3	190	2	17890503
Pubmed	Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis.	APOE CD40LG	8.87e-05	3	190	2	20705757
Pubmed	Interaction between PPARG Pro12Ala and ADIPOQ G276T concerning cholesterol levels in childhood obesity.	PPARG APOE	8.87e-05	3	190	2	18645733
Pubmed	Pleckstrin homology domain of G protein-coupled receptor kinase-2 binds to PKC and affects the activity of PKC kinase.	GRK2 BTK	8.87e-05	3	190	2	12679936
Pubmed	JNK2 is a positive regulator of the cJun transcription factor.	JUN MAPK9	8.87e-05	3	190	2	16973441
Pubmed	The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases.	MAPK9 MAPK10	8.87e-05	3	190	2	34502556
Cytoband	4q22.1	TIGD2 HERC6 HERC5	1.69e-04	26	190	3	4q22.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4q22	MMRN1 TIGD2 HERC6 HERC5	2.61e-04	74	190	4	chr4q22
GeneFamily	Aminoacyl tRNA synthetases, Class I	WARS1 IARS1 LARS1	3.31e-04	19	131	3	131
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RASGRF2 DOCK9 PLEKHM1 GRK2 GRK3 BTK ARHGEF6	7.63e-04	206	131	7	682
Coexpression	BAELDE_DIABETIC_NEPHROPATHY_DN	WARS1 IARS1 GRK5 PTGDS ITGB3 TGFBR3 FRY DST LRIG1 TLE4 PNMA2 FGF9 PLOD2 TOP2B	3.84e-06	437	189	14	M4665
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	FLNB SLC11A2 ATR DOCK9 GRK5 BAZ1B HNRNPH3 CEMIP PIKFYVE TGFBR3 USP6 JUN DST MDN1 LRIG1 BAZ1A TLE4 IL1RAP PLOD2 TP53BP2	4.17e-06	856	189	20	M4500
Coexpression	GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP	FNIP2 SLC11A2 WARS1 FMNL2 IFIT3 MKNK1 ZNF746 HERC6 HERC5	1.18e-05	193	189	9	M3303
Coexpression	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN	ZNF93 MAGEC3 FHOD3 TRIL USP6 SLC9A3 DST MTUS1 MAPK9	1.39e-05	197	189	9	M9910
Coexpression	GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	CYB5RL AP1S3 RTEL1 IPP ITGB3 NFIX CD40LG HERC6 ARHGEF6	1.51e-05	199	189	9	M8113
Coexpression	GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN	GPD2 DDR1 WARS1 LARS1 SRP19 ITGB3 IFIT3 JUN RAD1	1.57e-05	200	189	9	M8849
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	RASGRF2 DOCK9 OBSCN IFIT3 THEM4 DST MDN1 CD40LG HERC6 HERC5	1.52e-08	200	189	10	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	FLNB PDE2A RASGRF2 DOCK9 RALGAPA2 SLC5A4 MMRN1 TGFBR3 SLCO2A1	1.02e-07	185	189	9	f5e14181f45c37d13ee9e017a4c8bc248c353676
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AP1S3 SYNE1 SIPA1L3 XKR4 ZNF462 KLHL13 DIAPH3 HYDIN EPHA7	1.17e-07	188	189	9	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	Endothelial-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	PDE2A RASGRF2 DOCK9 GRK5 PTGDS MMRN1 TGFBR3 SLCO2A1 HAPLN3	1.34e-07	191	189	9	f702dfe88a9b04091dae87df61b2b4f43525f86a
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	FLNB WARS1 RASGRF2 SYNE1 DOCK9 RALGAPA2 MMRN1 SLC9C1 SLCO2A1	1.60e-07	195	189	9	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	FLNB WARS1 RASGRF2 SYNE1 DOCK9 RALGAPA2 MMRN1 SLC9C1 SLCO2A1	1.75e-07	197	189	9	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ARHGAP42 SYNE1 TGFBR3 DST MTUS1 NFIX KLHL13 CPLANE1 EPHA7	1.99e-07	200	189	9	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	Bronchial_Biopsy-Endothelial-Lymphatic\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	ATP8B3 PDE2A CYB5RL PPARG PKHD1L1 MMRN1 TRIL HERC5	7.48e-07	172	189	8	c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tnaive/CM_CD4\|GI_large-bowel / Manually curated celltypes from each tissue	CYB5RL OBSCN RBM28 IFIT3 THEM4 TIGD2 TLE4 HERC6	9.29e-07	177	189	8	eb87ea93e36a8f97442ec8515f658ee61932dc0f
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REP15 PNLIP MTERF1 PKHD1L1 ITGB3 MMRN1 CLCA2 UTY	1.19e-06	183	189	8	919c9861073d12fd12aecd7469b1478b13838c43
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SEMA6B PDE2A CYB5RL RALGAPA2 MMRN1 FRY SLCO2A1 HAPLN3	1.35e-06	186	189	8	055cc23c4db9aad2d6c62e62c8e58bfe5047c6b1
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	FLNB RASGRF2 DOCK9 RALGAPA2 PKHD1L1 INO80D MMRN1 SLCO2A1	1.40e-06	187	189	8	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	FLNB RASGRF2 DOCK9 RALGAPA2 PKHD1L1 MMRN1 TGFBR3 SLCO2A1	1.46e-06	188	189	8	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	COPD-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	SYNE1 GRK5 YES1 HNRNPH1 TGFBR3 LRIG1 DIAPH3 HYDIN	1.46e-06	188	189	8	186fe1ea328c942910190a4240262c0d8642ea3b
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	FLNB RASGRF2 DOCK9 GRK5 RALGAPA2 PKHD1L1 MMRN1 SLCO2A1	1.52e-06	189	189	8	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	AP1S3 EFCAB13 XKR4 ZNF462 LGI2 DIAPH3 HYDIN EPHA7	1.64e-06	191	189	8	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	FLNB WARS1 RASGRF2 SYNE1 DOCK9 RALGAPA2 PKHD1L1 SLCO2A1	1.64e-06	191	189	8	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	FLNB WARS1 RASGRF2 SYNE1 DOCK9 RALGAPA2 PKHD1L1 SLCO2A1	1.71e-06	192	189	8	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	AP1S3 EFCAB13 XKR4 JUN RIMKLB SLCO2A1 SERPINB11 KLHL13	1.78e-06	193	189	8	ca7c0a4ceb05bced90f6cdc53d278e547fb241e9
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	FLNB RASGRF2 DOCK9 GRK5 RALGAPA2 PKHD1L1 MMRN1 SLCO2A1	1.78e-06	193	189	8	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	FLNB RASGRF2 DOCK9 GRK5 RALGAPA2 PKHD1L1 MMRN1 SLCO2A1	1.78e-06	193	189	8	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	FLNB RASGRF2 DOCK9 RALGAPA2 PKHD1L1 INO80D MMRN1 SLCO2A1	1.85e-06	194	189	8	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA6B FLNB WARS1 RASGRF2 DOCK9 RALGAPA2 YES1 SLCO2A1	1.92e-06	195	189	8	818bc18c5834238e5f733cac6fe928ed0788f57d
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	PDE2A WARS1 DOCK9 FMNL2 MMRN1 ZNF462 TGFBR3 RIMKLB	1.99e-06	196	189	8	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPHP1 VWA3A SYNE1 CFAP74 CPLANE1 MAPK10 FLACC1 HYDIN	2.07e-06	197	189	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA6B REP15 RASGRF2 SYNE1 SLC5A4 LGI2 SLCO2A1 HAPLN3	2.07e-06	197	189	8	31bec97c3952c48031bd66a5dad16a70a61519c3
ToppCell	5'-Adult-Appendix-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE2A WARS1 DOCK9 RALGAPA2 PKHD1L1 MMRN1 MTUS1 SLCO2A1	2.15e-06	198	189	8	90e85fe7a0ab376a41666dfff6c0e95b7f1c9475
ToppCell	COVID-19-lung-Capillary_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	WARS1 DOCK9 GRK5 RALGAPA2 INO80D SLC5A4 SLCO2A1 CDC25B	2.15e-06	198	189	8	45419f2804b4be79bae6632e71c54e1af482d115
ToppCell	367C-Endothelial_cells\|367C / Donor, Lineage, Cell class and subclass (all cells)	FLNB PDE2A DOCK9 RALGAPA2 MMRN1 FRY MTUS1 SLCO2A1	2.23e-06	199	189	8	636ff80938907f137e955388797072ab45289062
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ARHGAP42 SYNE1 TGFBR3 DST MTUS1 NFIX KLHL13 EPHA7	2.23e-06	199	189	8	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA6B PDE2A DOCK9 RALGAPA2 MMRN1 MTUS1 SLCO2A1 HAPLN3	2.23e-06	199	189	8	6fb81388c5045e81c3849a7136bdff3f953f044e
ToppCell	367C-Endothelial_cells-Endothelial-A_(Artery)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	FLNB PDE2A DOCK9 RALGAPA2 MMRN1 FRY MTUS1 SLCO2A1	2.23e-06	199	189	8	c2d85f80037f209a4a329790f475d9f98f590262
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	IFIT3 CCNH JUN BAZ1A CD40LG HAPLN3 HERC6 HERC5	2.23e-06	199	189	8	d3f36ede2fade550ec8f21a0448e71e1ff579ee2
ToppCell	367C-Endothelial_cells-Endothelial-A_(Artery)\|367C / Donor, Lineage, Cell class and subclass (all cells)	FLNB PDE2A DOCK9 RALGAPA2 MMRN1 FRY MTUS1 SLCO2A1	2.23e-06	199	189	8	29ed081bd5204a32068b420f2244f3704891547b
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA6B DOCK9 RALGAPA2 PTGDS PKHD1L1 MMRN1 SLCO2A1 HAPLN3	2.32e-06	200	189	8	cb00760ae75c30b1cb8526534aabd4ffc7c21000
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	FLNB PDE2A DOCK9 RALGAPA2 MMRN1 TGFBR3 SLCO2A1 HAPLN3	2.32e-06	200	189	8	71979bbcc035d5b8882f1502b5a8ef248aaba45a
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLNB PDE2A DOCK9 RALGAPA2 MMRN1 TGFBR3 SLCO2A1 HAPLN3	2.32e-06	200	189	8	c55efd997392e99068b673542f56f1a209c5a6c8
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Bronchial_vessel\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	FLNB PDE2A DOCK9 RALGAPA2 MMRN1 TGFBR3 SLCO2A1 HAPLN3	2.32e-06	200	189	8	a18817d36b2b30a32e1513d36174bf98dfea2a92
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA6B PDE2A DOCK9 RALGAPA2 MMRN1 MTUS1 SLCO2A1 HAPLN3	2.32e-06	200	189	8	a3b09580738783c6bff31ea33d5188912e56b8a7
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	REP15 CSMD3 ZNF462 MTUS1 EHHADH HAPLN3 EPHA7	5.16e-06	158	189	7	6d2709b387945c015faa223c20d22b52a4082140
ToppCell	droplet-Lung-nan-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AP1S3 MDN1 GRK3 SERPINB12 NXF2 CLEC10A ARHGEF6	6.59e-06	164	189	7	a67dd181eba275c191f4d0cab13df30eaa3ad913
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THNSL1 HNRNPH1 THEM4 CD22 SGO2 DMRTA1 DIAPH3	6.59e-06	164	189	7	4307b002fb41ddfc7ab8a6bca66a60942c250052
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THNSL1 HNRNPH1 THEM4 CD22 SGO2 DMRTA1 DIAPH3	6.59e-06	164	189	7	1d84aa5b925f502ee9c5fa39714490f613a58028
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SEMA6B FLNB WARS1 DOCK9 RALGAPA2 MMRN1 SLCO2A1	7.13e-06	166	189	7	f7926ee266dcbf10df375cd921f1db5a2fa604f8
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A SYNE1 DOCK9 PKHD1L1 KCNU1 SLCO2A1 HERC6	8.02e-06	169	189	7	987ff79ad563825dd9877ea8ccb536758f8c6700
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPHP1 VWA3A CFAP74 CPLANE1 MAPK10 FLACC1 HYDIN	8.02e-06	169	189	7	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDR1 OBSCN PTGDS FMNL2 DST CLEC10A PLOD2	8.66e-06	171	189	7	4e856441063e9825b6f87a1d3dd19c77dae4662c
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 PPARG APOE ITGAL FMNL2 TGFBR3 GRK3	1.01e-05	175	189	7	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	COVID-19_Severe-CD4+_CTL\|COVID-19_Severe / disease group, cell group and cell class	SYNE1 DDIT4L XKR4 CEMIP CCNH TGFBR3 CD40LG	1.08e-05	177	189	7	34e9455790bae905dd91923792f4109d18b7686e
ToppCell	5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	WARS1 SYNE1 DOCK9 RALGAPA2 PKHD1L1 ITGB3 MMRN1	1.30e-05	182	189	7	fd786c88826ad3d5cc5c3d80f8e392d6be1b5267
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STXBP5L OBSCN CSMD3 PKHD1L1 HYDIN MYO16 EPHA7	1.39e-05	184	189	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STXBP5L OBSCN CSMD3 PKHD1L1 HYDIN MYO16 EPHA7	1.39e-05	184	189	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	5'-Adult-Appendix-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	WARS1 SYNE1 DOCK9 RALGAPA2 PKHD1L1 ITGB3 MMRN1	1.39e-05	184	189	7	453295362888c9a59d0e73c7a5b15914c50ff591
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STXBP5L OBSCN CSMD3 PKHD1L1 HYDIN MYO16 EPHA7	1.39e-05	184	189	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	droplet-Heart-nan-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA6B PDE2A DOCK9 PPARG FRY PHOSPHO1 ELOVL3	1.44e-05	185	189	7	a32d5cb596ebac80eb1ac301055e65d420879ec8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	VWA3A SYNE1 EFCAB13 XKR4 FRY TLE4 IL1RAP	1.44e-05	185	189	7	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	VWA3A SYNE1 EFCAB13 XKR4 FRY TLE4 IL1RAP	1.44e-05	185	189	7	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DDIT4L XKR4 ZNF462 LGI2 DIAPH3 HYDIN EPHA7	1.49e-05	186	189	7	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	Myeloid-B_(Activated_Macrophage)\|World / shred on cell class and cell subclass (v4)	FNIP2 PPARG ITGAL PGD DST BAZ1A BTK	1.49e-05	186	189	7	33d731a7883d75e4e7db83b641cdb1e9a39938bf
ToppCell	critical-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	WARS1 APOE FMNL2 IFIT3 HAPLN3 HERC6 HERC5	1.55e-05	187	189	7	72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad
ToppCell	droplet-Heart-nan-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA3A SEMA6B PDE2A PPARG FRY PHOSPHO1 ELOVL3	1.60e-05	188	189	7	9dfa2e0b73640459cdf88277291e3ab9c33e0217
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DDIT4L XKR4 ZNF462 LGI2 DIAPH3 HYDIN EPHA7	1.66e-05	189	189	7	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	FLNB DOCK9 GRK5 RALGAPA2 PKHD1L1 MMRN1 SLCO2A1	1.66e-05	189	189	7	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE2A DOCK9 RALGAPA2 PKHD1L1 MMRN1 UBR3 HAPLN3	1.71e-05	190	189	7	32400c62cb9de4c2b24af4206c21a0215ab12212
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE2A WARS1 DOCK9 RALGAPA2 PKHD1L1 MMRN1 UBR3	1.71e-05	190	189	7	b2bd2cb384bb8a5662064ed1aee68e905e1f780d
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	WWC3 SYNE1 DOCK9 GRK5 OBSCN TGFBR3 SLCO2A1	1.71e-05	190	189	7	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SEMA6B PDE2A YES1 PKHD1L1 ME3 MMRN1 CLCA2	1.71e-05	190	189	7	26e2237f65cb43723c5da853831b40df2982d6e4
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK9 RALGAPA2 PKHD1L1 SLC5A4 MMRN1 TGFBR3 SLCO2A1	1.71e-05	190	189	7	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RASGRF2 RTEL1 DOCK9 SLC5A4 MMRN1 LGI2 SLCO2A1	1.71e-05	190	189	7	06bfb62b94b0faf467ef93d5bc5d08924c770098
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SEMA6B PDE2A YES1 PKHD1L1 ME3 MMRN1 CLCA2	1.71e-05	190	189	7	a1514d2186eb4fe569971ab22dc0c17d353fb94a
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	GRK5 RALGAPA2 DST GRK3 CD22 NFIX UTY	1.71e-05	190	189	7	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SEMA6B PDE2A YES1 PKHD1L1 ME3 MMRN1 CLCA2	1.71e-05	190	189	7	0bb954a94317cfc742b9b6221bb80f8baa6d3ff1
ToppCell	facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FHOD3 PTGDS ME3 PPP1R3A CFAP20DC ASB11	1.77e-05	191	189	7	9d7d680da3979e256191b534ebd14c5383e0cf93
ToppCell	facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FHOD3 PTGDS ME3 PPP1R3A CFAP20DC ASB11	1.77e-05	191	189	7	543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SEMA6B PDE2A RASGRF2 DOCK9 YES1 SLC5A4 SLCO2A1	1.77e-05	191	189	7	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	FLNB DOCK9 RALGAPA2 PKHD1L1 INO80D MMRN1 SLCO2A1	1.83e-05	192	189	7	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	IFIT3 THEM4 CD40LG HAPLN3 HERC6 CDC25B HERC5	1.83e-05	192	189	7	e07b6892276c81c1227e94ca942f6820d89a7ca3
ToppCell	NS-critical-d_07-13-Myeloid-Monocyte-derived_Macrophage\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	WARS1 APOE FMNL2 IFIT3 HAPLN3 CLEC10A HERC5	1.90e-05	193	189	7	0dd83b21e164147abfd511a927615c40a28781a2
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	VWA3A LRIG1 NFIX CFAP74 CPLANE1 MAPK10 HYDIN	1.90e-05	193	189	7	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA3A PDE2A DOCK9 RALGAPA2 PKHD1L1 MMRN1 MTUS1	1.90e-05	193	189	7	bd0027fa97de41ae22ff64a61c8e217496f122ca
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SEMA6B PDE2A PKHD1L1 MMRN1 MTUS1 SLCO2A1 HAPLN3	1.90e-05	193	189	7	c0973a2c97deb7176c2f617c8760a55f7edc9839
ToppCell	COVID-19_Moderate-CD4+_T_activated\|World / disease group, cell group and cell class	DOCK9 IFIT3 THEM4 CD40LG HAPLN3 HERC6 HERC5	1.90e-05	193	189	7	c2a2a2c14a7085690262db5c2a70e38db67dee18
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	AP1S3 OBSCN ITGAL PKHD1L1 EPHA8	1.92e-05	77	189	5	a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPHP1 VWA3A SYNE1 CFAP74 MAPK10 HYDIN CFAP99	1.96e-05	194	189	7	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	critical-Myeloid-Monocyte-derived_Macrophage\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	WARS1 APOE FMNL2 IFIT3 HAPLN3 CLEC10A HERC5	1.96e-05	194	189	7	e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	WARS1 RASGRF2 SYNE1 DOCK9 PPARG YES1 SLC9C1	2.03e-05	195	189	7	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DOCK9 THEM4 DST LRIG1 CD40LG HERC6 CDC25B	2.03e-05	195	189	7	22191d361af136942508f1553ff41a626ed982ad
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	NPHP1 GRK5 PPARG CEMIP SDR9C7 FLACC1	2.05e-05	131	189	6	96d300958545714d18e905e860e95469c8ae4efa
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE2A DOCK9 PRND CEMIP MMRN1 SLCO2A1 HAPLN3	2.09e-05	196	189	7	9b53e3fdb23dbdfc2e7ce012c6b2ce50700c95d5
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	ARHGAP42 VWA3A SYNE1 YES1 HNRNPH1 MAPK10 HYDIN	2.09e-05	196	189	7	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	ARHGAP42 VWA3A SYNE1 YES1 HNRNPH1 MAPK10 HYDIN	2.09e-05	196	189	7	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	WARS1 WWC3 SYNE1 DOCK9 RALGAPA2 TGFBR3 SLCO2A1	2.09e-05	196	189	7	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	SEMA6B PDE2A RASGRF2 DOCK9 GRK5 SLC5A4 SLCO2A1	2.09e-05	196	189	7	b71b197cb92117dd9efaa13de000841901cc4ca8
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTGDS PKHD1L1 MMRN1 SLCO2A1 SGO2 DIAPH3 CDC25B	2.16e-05	197	189	7	76b61e60a757e58b465569538e632d6d9953e89a
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	WARS1 RASGRF2 SYNE1 DOCK9 MMRN1 SLC9C1 SLCO2A1	2.16e-05	197	189	7	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PDE2A PKHD1L1 MMRN1 RIMKLB SLCO2A1 HAPLN3 CBX2	2.16e-05	197	189	7	a78111171819db746af7b162c77f9a324453f3ce
ToppCell	Tracheal-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA6B PDE2A RASGRF2 PKHD1L1 SLC5A4 MMRN1 SLCO2A1	2.24e-05	198	189	7	77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d
ToppCell	MS-IIF-Lymphocyte-B-B_intermediate\|IIF / Disease, condition lineage and cell class	AP1S3 SIPA1L3 PKHD1L1 JUN CD22 BTK DNAH8	2.24e-05	198	189	7	d6b533c5e1d55e13b1e87ce3dbacb1564bcdcc64
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA3A PDE2A CYB5RL SYNE1 DOCK9 PKHD1L1 MMRN1	2.24e-05	198	189	7	99d6a64f3410dae3019161feef20a8f06081a24b
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	RASGRF2 DOCK9 IFIT3 LRIG1 HAPLN3 HERC6 HERC5	2.24e-05	198	189	7	ee71543559836fd59adc0da877b2ca538cba60cb
Drug	AC1L1B3Z	JUN DST MAPK9 CDC25B MAPK10 TP53BP2	1.82e-06	45	188	6	CID000001273
Drug	GN8	PRND PPP1R3A SLC25A43	2.20e-06	4	188	3	CID016122598
Drug	phenylglyoxylic acid	PNMA1 SYNE1 PRND PLEKHM1 PNMA2	3.68e-06	29	188	5	CID000011915
Drug	2f4b	TBPL1 SPTLC1 PPARG USP6	1.58e-05	19	188	4	CID006102812
Drug	AC1L3ZTY	JUN MAPK9 MAPK10	1.89e-05	7	188	3	CID000098120
Drug	AA100	JUN MAPK9 MAPK10	1.89e-05	7	188	3	CID010490261
Drug	cannabinol	APOE HNRNPH3 JUN ASMT	1.97e-05	20	188	4	CID000002543
Drug	BW245C	PPARG PTGDS PGD SLCO2A1 HTT	2.14e-05	41	188	5	CID000119304
Drug	Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	ZNF93 GRK5 ZNF576 CEMIP GRK2 CD22 NFIX OR1G1 ABHD8	3.98e-05	197	188	9	5100_DN
Drug	Indapamide [26807-65-8]; Up 200; 10.6uM; HL60; HT_HG-U133A	SIPA1L3 BAZ1B ATP10B PTGDS INO80D PAICS MTUS1 CD22 HERC6	3.98e-05	197	188	9	2361_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	SLC11A2 SIPA1L3 JUN MTUS1 CD22 SLCO2A1 CZIB UTY HERC5	3.98e-05	197	188	9	5600_DN
Drug	C75; Up 200; 10uM; MCF7; HT_HG-U133A	NPHP1 HTR2A USP29 ATP10B APOE ITGB3 IFIT3 CLCA2 FGF9	3.98e-05	197	188	9	6423_UP
Drug	Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; PC3; HT_HG-U133A	ZNF93 PDE2A HTR2A GRK5 ITGB3 MMRN1 BTK ABHD8 CPLANE1	4.30e-05	199	188	9	5731_UP
Drug	Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A	PDE2A ATP10B HNRNPH1 PPP1R3A GRK2 SLCO2A1 CD40LG FGF9 CBX2	4.48e-05	200	188	9	6032_UP
Drug	AC1L6EKE	JUN MAPK9 MAPK10	4.49e-05	9	188	3	CID000265720
Drug	vanadyl	PDE2A PIKFYVE JUN MTMR4 GRK2 GRK3 MTUS1 CD22 MAPK9 MAPK10 DNAH8	5.22e-05	307	188	11	CID000061671
Drug	JS-K	JUN MAPK9 MAPK10	6.37e-05	10	188	3	CID009572720
Drug	D-JNKI-1	JUN MAPK9 MAPK10	6.37e-05	10	188	3	ctd:C478085
Drug	hydroxysafflor yellow A	PPARG ITGB3 CD40LG	6.37e-05	10	188	3	ctd:C085278
Drug	Kinome_3024	MAPK9 MAPK10	6.78e-05	2	188	2	CID011539329
Drug	N-acetyl-S-(2-hydroxy-2-phenylethyl)-L-cysteine	PNMA1 PNMA2	6.78e-05	2	188	2	CID000119069
Drug	AC1NSWD2	SYNE1 TOP2B	6.78e-05	2	188	2	CID005318091
Drug	7-hydroxy-6-methoxyphthalide	PNMA1 PNMA2	6.78e-05	2	188	2	CID000152995
Drug	NSC636979	IARS1 LARS1	6.78e-05	2	188	2	CID000367344
Drug	Kinome_3019	MAPK9 MAPK10	6.78e-05	2	188	2	CID011658882
Drug	6-hydroxy-7-methoxyphthalide	PNMA1 PNMA2	6.78e-05	2	188	2	CID000196075
Drug	Kinome_3025	MAPK9 MAPK10	6.78e-05	2	188	2	CID011715520
Drug	N-acetyl-S-(1-phenyl-2-hydroxyethyl)cysteine	PNMA1 PNMA2	6.78e-05	2	188	2	CID000119298
Drug	Kinome_3027	MAPK9 MAPK10	6.78e-05	2	188	2	CID011640926
Drug	Kinome_3028	MAPK9 MAPK10	6.78e-05	2	188	2	CID011590363
Disease	Drug habituation	SYNE1 FHOD3 XKR4 CSMD3 MKNK1 EHHADH DNAH8	7.57e-06	115	182	7	C0013170
Disease	Drug abuse	SYNE1 FHOD3 XKR4 CSMD3 MKNK1 EHHADH DNAH8	7.57e-06	115	182	7	C0013146
Disease	Prescription Drug Abuse	SYNE1 FHOD3 XKR4 CSMD3 MKNK1 EHHADH DNAH8	7.57e-06	115	182	7	C4316881
Disease	Substance-Related Disorders	SYNE1 FHOD3 XKR4 CSMD3 MKNK1 EHHADH DNAH8	7.57e-06	115	182	7	C0236969
Disease	Drug Use Disorders	SYNE1 FHOD3 XKR4 CSMD3 MKNK1 EHHADH DNAH8	7.57e-06	115	182	7	C0013222
Disease	Drug Dependence	SYNE1 FHOD3 XKR4 CSMD3 MKNK1 EHHADH DNAH8	7.57e-06	115	182	7	C1510472
Disease	Substance Dependence	SYNE1 FHOD3 XKR4 CSMD3 MKNK1 EHHADH DNAH8	7.57e-06	115	182	7	C0038580
Disease	Substance Use Disorders	SYNE1 FHOD3 XKR4 CSMD3 MKNK1 EHHADH DNAH8	7.57e-06	115	182	7	C0038586
Disease	Organic Mental Disorders, Substance-Induced	SYNE1 FHOD3 XKR4 CSMD3 MKNK1 EHHADH DNAH8	7.57e-06	115	182	7	C0029231
Disease	Substance abuse problem	SYNE1 FHOD3 XKR4 CSMD3 MKNK1 EHHADH DNAH8	8.01e-06	116	182	7	C0740858
Disease	chemotherapy-induced alopecia, response to antimicrotubule agent	ME3 ZNF462 SERPINB12	3.67e-05	11	182	3	EFO_0005260, EFO_0005400
Disease	INSULIN RESISTANCE, SEVERE, DIGENIC	PPARG PPP1R3A	3.78e-05	2	182	2	C4016701
Disease	Bipolar Disorder	HTR2A SYNE1 DOCK9 APOE PTGDS GRK3 EHHADH NFIX ASMT CLEC10A DNAH8	1.97e-04	477	182	11	C0005586
Disease	Alzheimer disease, dementia, family history of Alzheimer’s disease	FHOD3 APOE ASB3 EGFLAM	2.20e-04	48	182	4	EFO_0009268, MONDO_0001627, MONDO_0004975
Disease	hereditary sensory neuropathy (implicated_via_orthology)	SPTLC1 DST	3.74e-04	5	182	2	DOID:0050548 (implicated_via_orthology)
Disease	cortical thickness	FNIP2 FLNB DOCK9 APOE FMNL2 RAB44 PLEKHM1 ZNF462 NPRL2 BAZ1A NFIX PYGB DMRTA1 DIAPH3 EBNA1BP2 MYO16 EPHA7	5.60e-04	1113	182	17	EFO_0004840
Disease	TYPE 2 DIABETES MELLITUS	GPD2 PPARG PPP1R3A	6.75e-04	28	182	3	125853
Disease	Type 2 diabetes mellitus	GPD2 PPARG PPP1R3A	6.75e-04	28	182	3	cv:C0011860
Disease	longevity, healthspan, parental longevity	APOE FLACC1 HTT	7.49e-04	29	182	3	EFO_0004300, EFO_0007796, EFO_0009762
Disease	hippocampus volume change measurement, age at assessment	APOE A2ML1 DIAPH3	7.49e-04	29	182	3	EFO_0008007, EFO_0021492
Disease	atherosclerosis (implicated_via_orthology)	APOE CD40LG	7.79e-04	7	182	2	DOID:1936 (implicated_via_orthology)
Disease	Parkinson's disease (biomarker_via_orthology)	GRK5 GRK2 GRK3	8.29e-04	30	182	3	DOID:14330 (biomarker_via_orthology)
Disease	response to statin, low density lipoprotein cholesterol measurement	APOE CEMIP	1.03e-03	8	182	2	EFO_0004611, GO_0036273
Disease	Williams Syndrome	BAZ1B LIMK1	1.03e-03	8	182	2	C0175702
Disease	Malignant neoplasm of breast	FLNB PDE2A WARS1 RASGRF2 SYNE1 EFCAB13 SPTLC1 OBSCN PPP1R3A CCNH JUN CLCA2 BTK FLACC1 HSPA14 TP53BP2	1.06e-03	1074	182	16	C0006142
Disease	hyperuricemia	SIPA1L3 BAZ1B LRIG1	1.10e-03	33	182	3	EFO_0009104
Disease	pancreatitis (implicated_via_orthology)	HTR2A PPARG	1.32e-03	9	182	2	DOID:4989 (implicated_via_orthology)
Disease	Cardiovascular Diseases	GRK5 APOE GRK2	1.42e-03	36	182	3	C0007222
Disease	Metabolic Diseases	HTR2A PPARG	1.65e-03	10	182	2	C0025517
Disease	transcription factor IIIb 90 kda subunit measurement	PIKFYVE EHHADH	1.65e-03	10	182	2	EFO_0020778
Disease	response to carboplatin, response to antineoplastic agent	FLNB LRIG1	1.65e-03	10	182	2	GO_0097327, GO_0097328
Disease	congestive heart failure (is_marker_for)	GRK5 GRK2 GRK3 CD40LG	1.68e-03	82	182	4	DOID:6000 (is_marker_for)
Disease	glomerulosclerosis (implicated_via_orthology)	PPARG APOE	2.01e-03	11	182	2	DOID:0050851 (implicated_via_orthology)
Disease	cytochrome p450 3a4 measurement	APOE PIKFYVE	2.01e-03	11	182	2	EFO_0020303
Disease	Congenital ichthyosis of skin	CASP14 SDR9C7	2.01e-03	11	182	2	cv:C0020758
Disease	oleoyl-linoleoyl-glycerol (18:1/18:2) [1] measurement	BAZ1B APOE	2.01e-03	11	182	2	EFO_0800332
Disease	airway wall thickness measurement	AP1S3 SDR9C7	2.40e-03	12	182	2	EFO_0006898
Disease	amyloid plaque accumulation rate	UBR3 IL1RAP	2.40e-03	12	182	2	EFO_0007646
Disease	RAC-beta serine/threonine-protein kinase measurement	APOE EHHADH	2.82e-03	13	182	2	EFO_0021989
Disease	skin melanoma (is_marker_for)	DDR1 AFF4	2.82e-03	13	182	2	DOID:8923 (is_marker_for)
Disease	transient cerebral ischemia (biomarker_via_orthology)	PPARG APOE ITGB3 CCNH HTT	2.96e-03	157	182	5	DOID:224 (biomarker_via_orthology)
Disease	lung carcinoma	DDR1 OGDH FRY MTUS1 ASB3 BRD9 HAPLN3 DMRTA1 IL1RAP	3.17e-03	482	182	9	EFO_0001071
Disease	glucose-dependent insulinotropic peptide measurement, glucose tolerance test	BTNL3 CLEC10A	3.28e-03	14	182	2	EFO_0004307, EFO_0008464
Disease	Williams-Beuren syndrome (implicated_via_orthology)	BAZ1B LIMK1	3.77e-03	15	182	2	DOID:1928 (implicated_via_orthology)
Disease	autoimmune thrombocytopenic purpura (is_implicated_in)	ITGB3 CD40LG	3.77e-03	15	182	2	DOID:8924 (is_implicated_in)
Disease	pancreatic adenocarcinoma (is_implicated_in)	MAPK9 MAPK10	3.77e-03	15	182	2	DOID:4074 (is_implicated_in)
Disease	interferon gamma measurement	EFCAB13 ZNF767P EPHA8	3.87e-03	51	182	3	EFO_0008165
Disease	Influenza	IFIT3 HERC6 HERC5	4.09e-03	52	182	3	C0021400
Disease	Colorectal Carcinoma	SLC11A2 RASGRF2 SYNE1 OBSCN IPP PPARG CSMD3 SLCO2A1 DMRTA1 DNAH8 EPHA7	4.38e-03	702	182	11	C0009402
Disease	Renal Insufficiency	PPARG APOE	4.84e-03	17	182	2	C1565489
Disease	glycochenodeoxycholate measurement	CEMIP GRK2	4.84e-03	17	182	2	EFO_0010490
Disease	glutarylcarnitine (C5-DC) measurement	FNIP2 CZIB	4.84e-03	17	182	2	EFO_0800030
Disease	hyperglycemia (implicated_via_orthology)	HTR2A GRK2	4.84e-03	17	182	2	DOID:4195 (implicated_via_orthology)
Disease	Psoriasis	AP1S3 PPARG APOE	5.29e-03	57	182	3	C0033860
Disease	Pustulosis of Palms and Soles	AP1S3 PPARG APOE	5.29e-03	57	182	3	C0030246
Disease	cup-to-disc ratio measurement	ARHGAP42 FLNB EFCAB13 FHOD3 FMNL2 TGFBR3 MTUS1 MYO16	5.41e-03	430	182	8	EFO_0006939
Disease	Sjogren's syndrome (is_implicated_in)	APOE HNRNPH1	5.42e-03	18	182	2	DOID:12894 (is_implicated_in)
Disease	insulin resistance	PPARG KCNU1 DMRTA1	5.82e-03	59	182	3	EFO_0002614
Disease	Carcinoma, Granular Cell	DDR1 PPARG APOE FGF9	5.86e-03	116	182	4	C0205644
Disease	Adenocarcinoma, Tubular	DDR1 PPARG APOE FGF9	5.86e-03	116	182	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	DDR1 PPARG APOE FGF9	5.86e-03	116	182	4	C0205642
Disease	Carcinoma, Cribriform	DDR1 PPARG APOE FGF9	5.86e-03	116	182	4	C0205643
Disease	Adenocarcinoma, Basal Cell	DDR1 PPARG APOE FGF9	5.86e-03	116	182	4	C0205641
Disease	Adenocarcinoma	DDR1 PPARG APOE FGF9	5.86e-03	116	182	4	C0001418
Disease	Lipoidosis	PPARG AP1S1	6.04e-03	19	182	2	C0023794
Disease	p-tau:beta-amyloid 1-42 ratio measurement	APOE EPHA7	6.04e-03	19	182	2	EFO_0007709
Disease	insulin sensitivity measurement, body mass index	PPARG FGF9	6.04e-03	19	182	2	EFO_0004340, EFO_0004471
Disease	ovulation	PLEKHM1 RLBP1	6.04e-03	19	182	2	GO_0030728

Protein segments in the cluster

Peptide	Gene	Start	Entry
FCFLAVGLVDVKVTQ	TRBV28	11	A0A5B6
KFVQALVGEDAVFSC	BTNL3	26	Q6UXE8
LLFKDFCLNEINEAV	GRK3	66	P35626
AEGGFTQIKCNTDIF	EGFLAM	721	Q63HQ2
NDFLKGCATLQVEIF	ARHGEF6	71	Q15052
TFLAGCQAKVEQAVE	APOE	11	P02649
LACKVDEFNVSSPQF	CCNH	111	P51946
QFGFELIGEKSIVCQ	CSMD3	691	Q7Z407
LLNCEEIKSQFEGFV	CD40LG	81	P29965
ETGVQCALSLQEFVK	BRD9	416	Q9H8M2
NCLVNDQGVVKVSDF	BTK	526	Q06187
KDFGECVIALQASVI	BAZ1B	1091	Q9UIG0
NCLVGENFTIKIADF	DDR1	771	Q08345
GSEKLTQECVFREQF	FGF9	126	P31371
VTKCFGQAQKFIFID	A2ML1	1041	A8K2U0
VFKEGSCLLADDNFV	HTR2A	221	P28223
SNEQKACKVLGIVFF	HTR2A	316	P28223
GSVCELDIIFNFEKA	AP1S1	96	P61966
GFVVCAFNRTVSKVD	PGD	26	P52209
VPTFELTLVFKQENC	DDIT4L	131	Q96D03
KQETAVNIGFACELL	ATP8B3	766	O60423
CVNVLLEFGAKAQLE	ASB11	146	Q8WXH4
VSQVLFAACELGVFD	ASMT	21	P46597
QFVDICIDQAKLEEF	DIAPH3	491	Q9NSV4
NIQNCTFRKFVALEG	CEMIP	886	Q8WUJ3
QVCKFLVESGAAVFA	TP53BP2	1006	Q13625
RCVVKGFSQQEVQFE	ATP10B	216	O94823
ITSCKGAQADVVLFF	ABHD8	166	Q96I13
NGFKEFTRQEQINCV	BAZ1A	751	Q9NRL2
VVSFIECGNALEKNA	AFF4	946	Q9UHB7
EEICQNLRGDVFQKF	GRK2	151	P25098
EELFSQVGPVKQCFV	RBM28	21	Q9NW13
GDKTISFNNCIVQLF	OR6C1	86	Q96RD1
AELQAFFQDCGAKER	RAB44	46	Q7Z6P3
AKCVQANAFIQAGIF	RAD1	56	O60671
FCDVQLQVGQESFKA	IPP	36	Q9Y573
CNEKDIVDFFAGLNI	GRSF1	261	Q12849
ECKIQFFSIAIGVTT	OR5H15	96	A6NDH6
GNVCELDIIFNFEKA	AP1S3	96	Q96PC3
EELGFQLFCNIIKSQ	CFAP99	96	D6REC4
CAAFDTVLGINVAVK	MAPK9	41	P45984
VNSLEGCQLIKFDSV	FAM189A1	121	O60320
VLIKLACVGTTFNEA	OR2G2	186	Q8NGZ5
VLAQVFTELAQKGFC	MDN1	4641	Q9NU22
GQDSLKEFVQFVCSD	NFIX	396	Q14938
GQEFDVRAKCVINAT	GPD2	276	P43304
FGQVVADVLCEFLEV	MAD2L2	11	Q9UI95
SVIFIKGNCASEEVI	MAGEC3	281	Q8TD91
CQEDDATIAKVGQLF	HAPLN3	286	Q96S86
VKIAFCQGFDKQVDV	MAPK10	16	P53779
SFVCDDFLKPQIITQ	LRIG1	486	Q96JA1
CSAVFENFIQEKEEL	FLACC1	281	Q96Q35
LACGNTKFEALTVVI	MTUS1	926	Q9ULD2
IIVETNVGKQFNFCS	PNLIP	436	P16233
GFEEFQKNEFEQLCV	MYO16	781	Q9Y6X6
AFPLEVVQKDSCFNS	IL1RAP	126	Q9NPH3
QFLCPKNVTDEQEGF	JUN	96	P05412
FTGDNCTIKLVEENA	MMRN1	1071	Q13201
QQALCNAKIFGEDEV	DST	5606	Q03001
QVFAELSAVCKPEAF	EHHADH	391	Q08426
AVNDVNGLKQCLAEF	EBNA1BP2	46	Q99848
EKSGCIVNNLAEFTV	FLNB	656	O75369
DQVVALACAFNKLEG	PDE2A	341	O00408
ASCGFLENVILAQKF	DNAH8	1986	Q96JB1
QAEATDFCKVLVVEF	HERC6	691	Q8IVU3
NENDETFVTLVGCFK	CYB5RL	206	Q6IPT4
GKFSNIVDKFVIVDC	CDC25B	426	P30305
GCSKEEIVQFFQGLE	HNRNPH3	26	P31942
AFFGKTNEQVVEVCT	SLC11A2	321	P49281
NIICFAELKLGFIAQ	KCNU1	471	A8MYU2
GLCTFLTSLFVEQNK	KCNU1	491	A8MYU2
EECLEAFKQVFGSLE	PNMA2	231	Q9UL42
EVQRFFSDCKIQNGA	HNRNPH1	26	P31943
VLIDGVECSDVKFFQ	PACS2	851	Q86VP3
FKNVESVAEIFDCLG	OC90	46	Q02509
EKIAEDQTCFFLQIL	RALGAPA2	201	Q2PPJ7
FQDVGACIALVSVKV	EPHA7	186	Q15375
CLFEFNEAFLVKLVQ	MTMR4	486	Q9NYA4
CKIFQTLNGAVDEVV	PLOD2	216	O00469
ECFLLGFSEQLEEQK	OR1G1	11	P47890
CDGETDQFSFKIVLV	PPP1R3A	181	Q16821
LIEGLDNQKVEFVAC	HERC5	236	Q9UII4
EDIKICDFGFAQNIT	OBSCN	6601	Q5VST9
FEQDFLTIGDLQLCK	PANK2	321	Q9BZ23
LEQIFCQFDSKLEAA	OGDH	326	Q02218
VDQKFQSIVIGCALE	BAG2	151	O95816
FDSVVVNGFVCTKNI	PIKFYVE	676	Q9Y2I7
NKECQDDFGITPLFV	ASB3	171	Q9Y575
NCLFNKGETFEVPEI	ATR	2496	Q13535
GKLEQVDVNLFCLVA	HTT	3081	P42858
FVEDENKFIFCNVLV	HYDIN	3361	Q4G0P3
DFCKVFLISGVTLDN	KLHL13	181	Q9P2N7
SVGEQVFAAECILSK	CBX2	6	Q14781
LKEVFRQFVEACGQA	DOCK9	2016	Q9BZ29
QVLAACFTEEGSQKL	SDR9C7	51	Q8NEX9
VVNAVFIKNELFGDC	CPLANE1	181	Q9H799
GGLKQTVCFINFIDN	ELOVL3	96	Q9HB03
IFSLCEKEEAQRNFQ	FNIP2	316	Q9P278
VLVDSNLVCKVSDFG	EPHA8	766	P29322
FCKGDVVQAIEQVLN	DMRTA1	351	Q5VZB9
EVNINKFCRIISEFA	FHOD3	1236	Q2V2M9
GFCNVILVKEENTRF	GPAT2	71	Q6NUI2
DRVCNQIEFLNTEFK	IFIT3	36	O14879
EIILSAFDNFKEVCG	FMNL2	281	Q96PY5
TVDIDAFQDALKIFC	EFCAB13	216	Q8IY85
AVTDKFGINCLIQFE	ME3	266	Q16798
SEFLCLEFDEVKVNQ	COMMD1	156	Q8N668
KFADGQQCSVPVFDI	INO80D	486	Q53TQ3
GFKDSLIVQVTFDCD	ITGB3	446	P05106
VEGFALVLLCSFQVA	FRY	741	Q5TBA9
IETECFKELNVFGPN	GRK5	516	P34947
DQKGSCFIQTLVDVF	CASP14	181	P31944
LVFLTGQFEIEKSCE	DHX40	276	Q8IX18
TAECLKALEQVFGSV	PNMA1	226	Q8ND90
NVPVENFFVKCNGAL	SDE2	41	Q6IQ49
LFQVRKVCAANFGDI	PPP4R1L	176	Q9P1A2
KGEKFQVTIIADDNC	BVES	211	Q8NE79
ETLQFCVIFQPTKAE	CFAP74	976	Q9C0B2
NENFKTIVEFECRGL	CZIB	91	Q9NWV4
IVTCQLQDADGKFLS	CD22	216	P20273
VQKAISEAGIFCLVN	NPHP1	251	O15259
QNGFTADDINKVVLC	HSPA14	321	Q0VDF9
LCFSVNGVFKEVEGQ	NXF2	496	Q9GZY0
CQGNKNILELIEFFE	MKNK1	101	Q9BUB5
NTDVNEFVIFICGVL	OR10R2	211	Q8NGX6
GSLDENCQEVLKFAT	PLEKHM1	791	Q9Y4G2
NCQEVLKFATRENGF	PLEKHM1	796	Q9Y4G2
LFAEAQITFQTKGCI	RTEL1	351	Q9NZ71
VENAKDIIACGFDIN	WARS1	216	P23381
DIIACGFDINKTFIF	WARS1	221	P23381
NQVKGIFGFTDSDCI	WARS1	261	P23381
ILKAEGKVESDFFCQ	UTY	81	O14607
CLTLSEKGFQQISFV	TOP2B	321	Q02880
FIQEKAKVVTFDCGN	SLC9C1	881	Q4G0N8
DVCSAVGLNVFLEKN	SRP19	51	P09132
LLQGKAEDCFQLFEE	SYNE1	1841	Q8NF91
SIVGCKAILIDDQVF	LGI2	276	Q8N0V4
EGTFLALVEQKVCSA	NBPF7P	341	P0C2Y1
NEAGFNFVRKCIQAV	ARHGAP42	391	A6NI28
ECSALQQDGVKEVFA	RHOG	156	P84095
GFNNTERTCDKEFII	RASGRF2	896	O14827
FETVNGDIFICTQKA	LARS1	316	Q9P2J5
QSKEVAIRIFQGCQF	PPARG	301	P37231
NVTGVDCVKGIVSFF	SLC9A3	241	P48764
FCKAQGFTEDTIVFL	PTGDS	166	P41222
QAASEQLRKFAEIFC	SIPA1L3	1761	O60292
NKLTQFFICVAGVFV	SLC35B3	76	Q9H1N7
IIKENFALECSPAFQ	SGO2	1171	Q562F6
FVLAIFCKRVNEQGA	SLC5A4	471	Q9NY91
FLKCKENGAFTVLVD	IARS1	296	P41252
FSGAVDCFRQIVKAQ	SLC25A43	246	Q8WUT9
GFQECIKGNVDLVFL	ITGAL	146	P20701
LLFNLGFVCDAQAKT	NPRL2	81	Q8WTW4
TANVEFCLDVFKELN	SERPINB11	6	Q96P15
FCLDVFKELNSNNIG	SERPINB11	11	Q96P15
TANTKFCFDLFQEIG	SERPINB12	6	Q96P63
FVDRAACFAIQKGLQ	SPTLC1	186	O15269
FGNCNGLAVVDFIQK	STXBP5L	656	Q9Y2K9
VFQSLDGIVVSANCK	CFAP20DC	26	Q6ZVT6
CVVGFQNSKFQRDLV	CLEC10A	56	Q8IUN9
TFSLVQAGDKVVCLV	CLCA2	301	Q9UQC9
SVFGNIKVFVLCQGL	SLCO2A1	26	Q92959
LADCEKTAVEFGNQL	ZNF767P	46	Q75MW2
SEEQLIAAKFCFAGL	PAICS	141	P22234
CGSFQEFVEKENLQP	TIGD2	156	Q4W5G0
VCAFDLTQVAAVFEG	SEMA6B	336	Q9H3T3
IFTDFKVVNVLAVCN	TBPL1	96	P62380
IECGKAFNQFSTLIT	ZNF93	176	P35789
ELCVFTIFGNEENGK	ZDHHC20	36	Q5W0Z9
TLFKIGEQFSVLGQC	ZNF778	161	Q96MU6
SCDRIKEEFQFLQAQ	TLE4	31	Q04727
DKVEGRKFFVSCNVQ	THEM4	201	Q5T1C6
EANVTKEAFVTGCIN	PRND	96	Q9UKY0
DFNKFILCNLTVEAV	TRIL	581	Q7L0X0
EDIAQGTKCTLEFQV	TMED7	51	Q9Y3B3
CFETFPDKVAIQLND	PYGB	326	P11216
QKFAERDGCVPVFQV	XKR4	561	Q5GH76
ANFEFELQLSLICKA	USP29	426	Q9HBJ7
FSLGCTEEEVQKFVL	MTERF1	301	Q99551
LQFVAKQGACFEVIL	PHOSPHO1	106	Q8TCT1
KQGACFEVILISDAN	PHOSPHO1	111	Q8TCT1
VGVESDFDFCQTAIK	THNSL1	431	Q8IYQ7
NVGFIAFDKACNLDV	RIMKLB	281	Q9ULI2
KAVAQFVLETEDCVF	REP15	196	Q6BDI9
EETQINGFCIIENFK	RLBP1	191	P12271
FKNVCSGETNVIFIT	PKHD1L1	3616	Q86WI1
EKLIQFCAIDELGTN	SAP30BP	166	Q9UHR5
CQIVNVAAEIFLKSG	TOPAZ1	1411	Q8N9V7
QVLQGFSVDKGEFTC	UBR3	1346	Q6ZT12
GIDFSLKNETVAICV	ZNF462	2476	Q96JM2
FVAQKLQGVLFICFT	ZNF576	61	Q9H609
LADCEKTAVEFGNQL	ZNF746	46	Q6NUN9
CGFVFDDVSAILDNK	TMTC3	26	Q6ZXV5
KVQLSVSGFLCAFEI	USP6	781	P35125
CSKALEFQVPLVFNE	WWC3	656	Q9ULE0
VLEEGTNVVQKICFS	VWA3A	116	A6NCI4
TKAEQELGFAIQTCF	TGFBR3	626	Q03167
NILVGENLVCKIADF	YES1	401	P07947
CLVRENKNVVVADFG	LIMK1	466	P53667